前往化源商城

Neuroscience 2002-01-01

Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult.

M P Lafuente, M P Villegas-Pérez, I Sellés-Navarro, S Mayor-Torroglosa, J Miralles de Imperial, M Vidal-Sanz

文献索引:Neuroscience 109(1) , 157-68, (2002)

全文:HTML全文

摘要

In adult Sprague-Dawley rats we have investigated retinal ganglion cell survival after transient intervals of retinal ischemia of 30, 45, 60, 90 or 120 min duration, induced by ligature of the ophthalmic vessels. Animals were killed 5, 7, 14, 21, 30, 60, 90 or 180 days later and densities of surviving retinal ganglion cells were estimated in retinal whole mounts by counting cells labelled with diAsp. This dye was applied, 3 days prior to death, to the ocular stump of the intraorbitally transected optic nerve. We found that retinal ganglion cell loss after retinal ischemia proceeds for different lengths of time. All the ischemic intervals induced loss of retinal ganglion cells whose severity and duration was related to the length of the ischemic interval. Following 30 or 45 min of ischemia, cell loss lasted 14 days and caused the death of 46 or 50%, respectively, of the population of retinal ganglion cells. Sixty, 90 or 120 min of retinal ischemia were followed by a period of cell loss that lasted up to 90 days and caused the death of 75%, 87% or 99%, respectively, of the population of retinal ganglion cells. We conclude that retinal ganglion cell loss after retinal ischemia is an ongoing process that may last up to 3 months after the injury and that its severity and duration are determined by the ischemic interval.

相关化合物

结构式 名称/CAS号 全部文献
4-[2-[4-(双十六烷基氨基)苯基]乙烯基]-1-甲基吡啶碘化物 结构式 4-[2-[4-(双十六烷基氨基)苯基]乙烯基]-1-甲基吡啶碘化物
CAS:114041-00-8